Summit Partners Public Asset Management, LLC Guardant Health, Inc. Transaction History

Summit Partners Public Asset Management, LLC

$2.79 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $10.1 Million - $14.2 Million	-79,532 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$99.96 - $135.93 $28,488 - $38,740	-285 Reduced 0.36%	79,532 $10.3 Million
Q3 2020 Nov 16, 2020	SELL	$80.32 - $111.8 $13.6 Million - $18.9 Million	-168,896 Reduced 67.91%	79,817 $8.92 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $3.41 Million - $5.49 Million	56,300 Added 29.26%	248,713 $20.2 Million
Q1 2020 May 15, 2020	SELL	$59.04 - $88.81 $5.17 Million - $7.78 Million	-87,587 Reduced 31.28%	192,413 $13.4 Million
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $6.54 Million - $9.1 Million	109,931 Added 64.64%	280,000 $21.9 Million
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $6.26 Million - $11 Million	100,071 Added 142.96%	170,069 $10.9 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $4.48 Million - $6.38 Million	69,998 New	69,998 $6.04 Million

Others Institutions Holding GH

# of Institutions

324

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

Vanguard Group Inc Valley Forge, PA

11.7M
Shares

$411 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.2M
Shares

$394 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.1M
Shares

$355 Million
0.04% of portfolio
Cadian Capital Management, LP New York, NY

6.93M
Shares

$243 Million
8.13% of portfolio
Deep Track Capital, LP Greenwich, CT

6M
Shares

$211 Million
5.07% of portfolio

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Account